A vascular surgery technique pioneered at UT Southwestern Medical Center, in which veins are removed from the thigh to repair the aorta does not create blood-flow problems and painful side effects in a majority of patients, researchers report.
Being moderately overweight or obese appears to increase the risk for developing coronary heart disease events independent of traditional cardiovascular risk factors, according to a meta-analysis of previously published studies in the September 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
The use of some asthma medications may lower the risk of cardiovascular disease in patients with asthma, shows a new study from the University of Southern California.
A new study shows that patients with pulmonary hypertension who receive a placebo during a clinical trial may experience clinical deterioration.
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood.
Mayo Clinic researchers have found that first-degree relatives (i.e., parents, siblings, children) of patients with primary biliary cirrhosis (PBC) are more likely to have the biomarker of the disease in their blood.
The focus of World Suicide Prevention Day this year is on suicide prevention from youth to old age. This theme has been adopted to emphasize that people of all ages commit suicide and that actions to prevent suicide included in national responses should meet the needs of different age groups.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
Health Canada is advising Canadians not to use the unauthorized product Colloidal Silver Water 20ppm, because of the potential health risk to consumers.
Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.